Specialty Chemicals

Showing 117 articles
Business

Galenica's Five-Year Surge: A 90% Return for Patient Investors

Swiss healthcare group Galenica has delivered robust returns for long-term shareholders, with a total return of 90% over five years, significantly outpacing the broader market. While recent performance has moderated, the stock's journey highlights the value of consistent earnings growth and dividends.

Business

Beyond the Numbers: A Tale of Two Markets in Apparel Retail's Q3 Earnings

The third-quarter earnings season for apparel retailers revealed a stark divergence. While some brands like Abercrombie & Fitch soared on strong results, others, including Tilly's and Torrid, faced investor skepticism despite meeting top-line expectations. We analyze the performance, the shifting retail landscape, and what it signals for the sector's future.